SCHEMBL23744819

SCHEMBL23744819

CC(=O)c1ccc2nc(-c3c(O)c(C)cn3C)[nH]c2c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC6 Q9UBN7 2/20 0.47
HDAC3 O15379 1/20 0.47
HDAC7 Q8WUI4 1/20 0.47
HDAC9 Q9UKV0 1/20 0.47
CHEK2 O96017 5/20 0.45
NPBWR1 P48145 1/20 0.45
BRD4 O60885 1/20 0.44
RAB9A P51151 1/20 0.44
F2 P00734 1/20 0.44
F10 P00742 1/20 0.44
PLG P00747 1/20 0.44
PLAU P00749 1/20 0.44
PLAT P00750 1/20 0.44
PRSS1 P07477 1/20 0.44
DGAT1 O75907 1/20 0.43
HSP90AA1 P07900 1/20 0.43
ESR2 Q92731 1/20 0.43
TDP1 Q9NUW8 1/20 0.43
THRB P10828 1/20 0.41
PKN1 Q16512 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24630423 0.88 CHEK2 (0.46) HDAC6HDAC3HDAC7HDAC9CHEK2
SCHEMBL12582121 0.86 HDAC6 (0.44) HDAC6HDAC3HDAC7HDAC9CHEK2
SCHEMBL23682677 0.86 HDAC6 (0.42) HDAC6HDAC3HDAC7HDAC9CHEK2
SCHEMBL23815554 0.83 BRD4 (0.44) HDAC6HDAC3HDAC7HDAC9CHEK2
SCHEMBL23745079 0.80 CHEK2 (0.47) HDAC6HDAC3HDAC7HDAC9CHEK2
SCHEMBL23745062 0.80 RAB9A (0.51) HDAC6HDAC3HDAC7HDAC9CHEK2
SCHEMBL26242966 0.78 CHEK2 (0.48) HDAC6HDAC3HDAC7HDAC9CHEK2
SCHEMBL23682745 0.77 HDAC6 (0.42) HDAC6HDAC3HDAC7HDAC9CHEK2
SCHEMBL12582122 0.76 BRD4 (0.45) HDAC6HDAC3HDAC7HDAC9CHEK2
SCHEMBL23815542 0.76 BRD4 (0.43) HDAC6HDAC3HDAC7HDAC9CHEK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4257128-A2 METHODS AND COMPOUNDS FOR THE TREATMENT OF GENETIC DISEASE Design Therapeutics, Inc. (US) 2023-10-11 EP disclosed
WO-2023133284-A2 COMPOUNDS AND METHODS FOR TREATING FRIEDREICH'S ATAXIA Design Therapeutics, Inc. (US) 2023-07-13 WO disclosed
WO-2022150555-A2 METHODS AND COMPOUNDS FOR TREATING FRIEDREICH'S ATAXIA Design Therapeutics, Inc. (US) 2022-07-14 WO disclosed
WO-2022126000-A1 METHODS AND COMPOUNDS FOR MODULATING MYOTONIC DYSTROPHY 1 Design Therapeutics, Inc. (US) 2022-06-16 WO disclosed
WO-2021158707-A1 METHODS AND COMPOUNDS FOR THE TREATMENT OF GENETIC DISEASE Design Therapeutics, Inc. (US) 2021-08-12 WO disclosed